Medicare Enrolled

Dr. Sam Bebawy, MD FCCP

Critical Care Medicine · Holmdel, NJ
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Low-engagement
719 N BEERS ST, Holmdel, NJ 07733
7322641001
In practice since 2006 (20 years)
NPI: 1396717971 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bebawy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bebawy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bebawy

Dr. Sam Bebawy is a critical care medicine specialist in Holmdel, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bebawy performed 1,211 Medicare services across 516 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bebawy received a total of $19,263 from 53 pharmaceutical and/or device companies across 833 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bebawy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 36% volume in NJ $19,263 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,211
Medicare services
Top 36% in NJ for critical care medicine
516
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
662 $45 $95
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
284 $95 $168
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
77 $30 $126
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
77 $36 $70
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
77 $45 $90
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function.
19 $32 $287
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
15 $102 $389
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,263
Total received (2018-2024)
Avg $2,752/year across 7 years
Top 7% in NJ for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
833
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,263 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,951
2023
$4,445
2022
$3,480
2021
$2,516
2020
$1,111
2019
$2,195
2018
$2,564

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,154
GlaxoSmithKline, LLC.
$401
Noah Medical Corporation
$185
GENZYME CORPORATION
$179
Mallinckrodt Hospital Products Inc.
$174
Actelion Pharmaceuticals US, Inc.
$146
United Therapeutics Corporation
$143
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
Electromed, Inc.
$99
Inspire Medical Systems, Inc.
$84
Insmed, Inc.
$52
HARMONY BIOSCIENCES LLC
$48
Optinose US, Inc.
$48
Baxter Healthcare
$36
Mylan Specialty L.P.
$35
ANI Pharmaceuticals, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$17
CSL Behring
$17
Top 3 companies account for 58.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,170
GlaxoSmithKline, LLC.
$3,223
Actelion Pharmaceuticals US, Inc.
$1,365
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,238
Medical Graphics Corporation
$1,000
Mallinckrodt Hospital Products Inc.
$712
GENZYME CORPORATION
$557
United Therapeutics Corporation
$519
Electromed, Inc.
$497
Insmed, Inc.
$446
Mylan Specialty L.P.
$427
Takeda Pharmaceuticals U.S.A., Inc.
$380
Harmony Biosciences LLC
$371
ANI Pharmaceuticals, Inc.
$326
Regeneron Healthcare Solutions, Inc.
$325
Philips Electronics North America Corporation
$305
Shire North American Group Inc
$282
Grifols USA, LLC
$251
Bayer HealthCare Pharmaceuticals Inc.
$246
Sunovion Pharmaceuticals Inc.
$223
Exeltis, USA Inc.
$196
Optinose US, Inc.
$189
Axsome Therapeutics, Inc.
$185
Noah Medical Corporation
$185
Chiesi USA, Inc.
$173
Bayer Healthcare Pharmaceuticals Inc.
$167
CHIESI USA, INC.
$127
HARMONY BIOSCIENCES LLC
$117
Baxter Healthcare
$114
Gilead Sciences, Inc.
$103
E.R. Squibb & Sons, L.L.C.
$102
Inspire Medical Systems, Inc.
$84
Circassia Pharmaceuticals Inc
$69
Teva Pharmaceuticals USA, Inc.
$68
Horizon Pharma plc
$58
Paratek Pharmaceuticals, Inc.
$56
Advanced Respiratory, Inc
$48
Covis Pharma GmBH
$47
Horizon Therapeutics plc
$45
Genentech USA, Inc.
$39
Nabriva Therapeutics, plc
$30
Janssen Pharmaceuticals, Inc
$29
JAZZ PHARMACEUTICALS INC.
$28
CSL Behring
$17
Lilly USA, LLC
$15
Allergan Inc.
$15
Amgen Inc.
$15
Merck Sharp & Dohme LLC
$15
Phadia US Inc.
$15
Mallinckrodt Enterprises LLC
$14
Vertical Pharmaceuticals, LLC
$14
Merck Sharp & Dohme Corporation
$14
ADVANCED RESPIRATORY, INC
$11
Top 3 companies account for 45.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · CLEVIPREX · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · FARXIGA · FASENRA · GALAXY · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · INSPIRE · ImmunoCAP · JARDIANCE · LINZESS · LONHALA MAGNAIR · LORZONE · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · RAYOS · Repatha · Respiratoriy Care Undiv · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XYREM · Xenleta · Xhance · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for critical care medicine in NJ.

Looking for a critical care medicine specialist in Holmdel?
Compare critical care medicines in the Holmdel area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical care medicines within 10 mi
107
Per 100K population
16.6
County median income
$122,727
Nearest hospital
BAYSHORE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bebawy is a remote monitoring specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bebawy experienced with remote patient monitoring device, 30 days?
Based on Medicare claims data, Dr. Bebawy performed 662 remote patient monitoring device, 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bebawy receive payments from pharmaceutical companies?
Yes. Dr. Bebawy received a total of $19,263 from 53 companies across 833 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bebawy's costs compare to other critical care medicines in Holmdel?
Dr. Bebawy's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bebawy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →